Visium Asset Management’s AbbVie ABBV Stock Holding History

Visium Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-159,691	Closed	-$8.69M	–	579
2015 Q3	$8.69M	Buy	+159,691	New	+$10.4M	0.12%	188
2015 Q1	–	Sell	-8,000	Closed	-$524K	–	1007
2014 Q4	$524K	Sell	8,000 -3,900	-33%	-$246K	0.01%	732
2014 Q3	$687K	Buy	11,900 +2,700	+29%	+$150K	0.01%	672
2014 Q2	$519K	Buy	+9,200	New	+$483K	0.01%	708

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Visium Asset Management's ABBV Position: Q4 2015 in Review

Visium Asset Management sold out of AbbVie (ABBV) in Q4 2015, closing a stake of 159,691 shares — an estimated $8.69M sold.

Visium Asset Management first reported a position in ABBV in Q2 2014 and held it in 4 quarters. The position peaked at $8.69M in Q3 2015. 1,637 funds tracked by Wall St. Rank hold ABBV as of Q4 2015.

Visium Asset Management reported no remaining AbbVie position as of Q4 2015 after selling out during the quarter.
Visium Asset Management sold 159,691 AbbVie shares in Q4 2015, an estimated $8.69M.
Visium Asset Management first reported a position in AbbVie in Q2 2014 and held it in 4 quarters.
Visium Asset Management's AbbVie position peaked at $8.69M in Q3 2015.
1,637 funds tracked by Wall St. Rank held AbbVie as of Q4 2015.

Based on Visium Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.